| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |